Bungie's former game director explains where one of Destiny 2's most iconic characters originally came from, and what the ...

Forbes contributors publish independent expert analyses and insights. News and opinion about video games, television, movies and the internet. This voice experience is generated by AI. Learn more.

With the launch of The Edge of Fate expansion for Destiny 2, all players have their Power levels reset to a much lower number than usual. This change affects all players, even those who do not own the ...

AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the global leader in dental technology, today announced the release of its 2026 Catalyst Index, the fifth edition of its annual benchmarking ...

Henry Schein One, the global leader in dental technology, today announced the release of its 2026 Catalyst Index, the fifth edition of its annual benchmarking report analyzing performance across tens ...

Syracuse, N.Y. – In a “full-circle moment,” Destiny USA’s owner is buying the largest mall in Rhode Island after losing three malls to foreclosure over the past two years. Rhode Island Superior Court ...

Angelini Pharma has agreed to acquire all outstanding shares of Catalyst Pharmaceuticals (CPRX) for $31.50 per share in cash, for a total equity value of approximately $4.1B. The deal has been ...

Backed by a full gospel choir, the performance showed why the Alabama band was worthy of their win for Group of the Year ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...